Search alternatives:
teer decrease » greater decrease (Expand Search)
0 decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
teer decrease » greater decrease (Expand Search)
0 decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
11281
Effect of H3 haplotype on serum HDL-cholesterol levels in women.
Published 2013“…In obese females, calorically restricted (−15% kcal) HF diet increased HDL-C from 50.11±11.60 mg/dl to 52.29±10.38 mg/dl in H3 haplotype carriers and decreased HDL-C from 47.99±12.90 mg/dl to 45.49±8.95 mg/dl in H3 non-carriers.…”
-
11282
-
11283
-
11284
-
11285
-
11286
-
11287
-
11288
-
11289
DIGESTIBILITY AND PALATABILITY OF DIETS WITH PROPOLIS EXTRACT FOR DOGS
Published 2019“…Two experiments were conducted, the first consisting of a digestibility trial with the inclusion of different propolis extracts (FT0,55, FT0,59, FT2,59, FT2,11). …”
-
11290
-
11291
<i>CEP55</i> knockdown induces cell death in neural progenitors of human cerebral organoid.
Published 2021“…One-way ANOVA (Kruskal–Wallis test) performed; *p< 0.05, ** p < 0.01, scale = 50 μm.</p>…”
-
11292
-
11293
Lack of oligodendrocytes after DTA-mediated ablation of <i>C1ql1</i>-expressing OPCs.
Published 2024“…Data are represented as mean ± SEM. P7: <i>n</i> = 3 animals. P15: <i>n</i> = 4 animals. …”
-
11294
Table_2_Clinical effectiveness of nimodipine for the prevention of poor outcome after aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis.DOC
Published 2022“…Remarkably, we found a poor outcome and mortality were both significantly lower among patients with aSAH, with the mean age < 50 than that mean age ≥ 50 by subgroup analysis. …”
-
11295
Table_6_Clinical effectiveness of nimodipine for the prevention of poor outcome after aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis.DOC
Published 2022“…Remarkably, we found a poor outcome and mortality were both significantly lower among patients with aSAH, with the mean age < 50 than that mean age ≥ 50 by subgroup analysis. …”
-
11296
Table_1_Clinical effectiveness of nimodipine for the prevention of poor outcome after aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis.DOC
Published 2022“…Remarkably, we found a poor outcome and mortality were both significantly lower among patients with aSAH, with the mean age < 50 than that mean age ≥ 50 by subgroup analysis. …”
-
11297
Table_5_Clinical effectiveness of nimodipine for the prevention of poor outcome after aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis.DOC
Published 2022“…Remarkably, we found a poor outcome and mortality were both significantly lower among patients with aSAH, with the mean age < 50 than that mean age ≥ 50 by subgroup analysis. …”
-
11298
Table_3_Clinical effectiveness of nimodipine for the prevention of poor outcome after aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis.DOC
Published 2022“…Remarkably, we found a poor outcome and mortality were both significantly lower among patients with aSAH, with the mean age < 50 than that mean age ≥ 50 by subgroup analysis. …”
-
11299
Table_4_Clinical effectiveness of nimodipine for the prevention of poor outcome after aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis.DOCX
Published 2022“…Remarkably, we found a poor outcome and mortality were both significantly lower among patients with aSAH, with the mean age < 50 than that mean age ≥ 50 by subgroup analysis. …”
-
11300
The interaction between paxillin and vinculin in adhesions is spatially regulated by the activity of the RhoGTPases.
Published 2012“…Error bars are standard error of the mean from cells used for FRET calculations. (E) Quantitation of average FRET efficiency of mRFP-paxillin and vinculin-YFP in all adhesions of cells in the presence of vehicle (dH<sub>2</sub>0) or 50 μM Rac1 inhibitor (NSC23766). …”